TGFβ(1 )activates c-Jun and Erk1 via α(V)β(6 )integrin by Luettich, Karsta & Schmidt, Christian
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Molecular Cancer
Open Access Short communication
TGFβ1 activates c-Jun and Erk1 via αVβ6 integrin
Karsta Luettich1 and Christian Schmidt*2
Address: 1Department of Dermatology, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York, 10021, USA and 
2Department of Surgical Oncology and Molecular Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 
Houston, Texas 77030, USA
Email: Karsta Luettich - karsta.luettich@molecular-cancer.org; Christian Schmidt* - christian.schmidt@molecular-cancer.org
* Corresponding author    
αVβ6c-JunMEKK1TGFβ1Erk1focal adhesioncytoskeleton
Abstract
Transforming growth factor β (TGFβ) plays an important role in animal development and many
cellular processes. A variety of cellular functions that are required for tumor metastasis are
controlled by integrins, a family of cell adhesion receptors. Overexpression of αVβ6 integrin is
associated with lymph node metastasis of gastric carcinomas. It has been demonstrated that a full
TGFβ1 signal requires both αVβ6 integrin and SMAD pathway. TGFβ1 binds to αVβ6 via the DLXXL
motif, a freely accessible amino acid sequence in the mature form of TGFβ1. Binding of mature
TGFβ1 to  αVβ6 leads to immobilization and tyrosine phosphorylation of proteins, which are
associated with focal adhesions, a hallmark of integrin-mediated signal transduction. Here, we show
that binding of mature TGFβ1 recruits the mitogen-activated protein kinase kinase kinase 1
(MEKK1), a mediator of c-Jun activation, and the extracellular signaling-regulated kinase-1 (Erk1)
to focal adhesions. In addition, the p21-activated kinase 1 (PAK1) is associated with focal adhesions
and differentially phosphorylated upon TGFβ1 stimulation. We conclude that TGFβ1 activates c-Jun
via the MEKK1/p38 MAP kinase pathway and influences cytoskeletal organization. These finding
may provide a link between TGFβ1 and the metastatic behavior of cancers.
Findings
The transforming growth factor pathway plays a central
role in cellular proliferation, recognition, differentiation,
apoptosis and specification of developmental fate, during
embryogenesis as well as in mature tissues [1,2]. Nearly
thirty members have been described in human, many
orthologs are known in other vertebrates. Four are known
in  Caenorhabditis elegans and seven in Drosophila mela-
nogaster. The family is divided into three subfamilies. One
subfamily contains of the bone morphogenetic proteins
(BMP) plus the growth and differentiaion factors (GDF).
The second family consists of the transforming growth
factor β and activin and nodal proteins. The last family
comprises of ligand antagonists such as inhibin-α [3].
TGFβ signaling generally has a negative effect on cell
growth. Inactivation of this pathway contributes to tum-
origenesis. The TGFβ protein is released as an inactive
'latent' complex, comprising a TGFβ dimer in a non-cova-
lent complex with two prosegments, to which one of sev-
eral 'latent TGFβ-binding proteins' is often linked. This
latent complex represents an important safeguard against
'inadvertent' activation, and may stabilize and target
latent TGFβ to the extracellular matrix, where it is seques-
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tered. The matrix thus acts as a reservoir from which TGFβ
can readily be recruited without the need for new
synthesis.
The secretion of TGFβ as a latent complex necessitates the
existence of a regulated activation process, which is most
probably mediated through the activities of proteases that
preferentially degrade the TGFβ prosegments and thereby
release the highly stable, active TGFβ dimer. Because plas-
min activates latent TGFβ and plasminogen is converted
into plasmin at sites of cell migration and invasion; it is
assumed that endothelial and tumor cells are exposed to
active TGFβ.
TGFβ signaling is mediated by a heterotetrameric complex
of two trans-membrane receptor serine/threonine kinases,
containing a type II ligand binding receptor (TGFβ-RII)
and a type I signaling receptor (TGFβ-RI). Smads 2 and 3
are direct substrates of TGFβ-RI and, together with the
common mediator, Smad4, play key roles as cytoplasmic
signaling mediators. Although the Smad pathway has
received much attention in the past years, it is now appre-
ciated that the activated receptor complex can also signal
through other pathways, such as those involving the
mitogen-activated protein kinases (MAPKs), phosphoi-
nositol-3 kinase (PI3K), and PP2A/p70s6K, though the
molecular details of this coupling are still obscure. The rel-
ative importance and interplay of these various pathways
in the changing responses of cells to TGFβ are just begin-
ning to be probed [4].
In mammal cells, there are three TGFβs, TGFβ1, TGFβ2 and
TGFβ3, which are encoded by different genes and which
all function through the same receptor system. Of these,
TGFβ1 is most frequently upregulated in tumor cells and is
the focus of most studies on the role of TGFβ in
tumorigenesis.
The integrin family of cell adhesion molecules mediates
cellular contacts to the extracellular matrix (ECM) or cell
counter receptors, thereby regulating development, cell
motility, cell polarity, cell growth and survival [5]. Ligand
binding to integrins leads to integrin clustering and
recruitment of actin filaments and signaling proteins to
the cytoplasmic domain of integrins, referred to as focal
complexes when they are still nascent and in the process
of forming, or focal adhesions (FAs) when they have
matured into larger complexes. The formation of cell
adhesion complexes assures substrate adhesion as well as
targeted location of Actin filaments and signaling compo-
nents. Cell adhesion complexes are also essential for
establishing cell polarity, directed cell migration, and
maintaining cell growth and survival [6,7].
The integrin-actin cytoskeleton connection is highly
dynamic and is differentially regulated in different loca-
tions of the cell. At the leading edge of migrating cells,
integrins bind the ECM, recruit the actin cytoskeleton and
initiate local reorganization of the actin network, promot-
ing different types of membrane protrusion. At the rear of
the cell, integrins detach from the ECM, dissolve the link
to the cytoskeleton and are, at least partially, recycled to
the front of the cell.
Signaling pathways, which depend on localized integrin
activation have also been reported; this is essential for the
reorientation of the microtubular network and the
directed movement of cells. Complexity is added by the
fact that integrin-associated molecules are multifunc-
tional. Integrin-linked actin binding proteins attach to sig-
naling molecules and function as platforms, bringing
kinases and substrates together. Integrin-bound signaling
molecules, on the other hand, bind to actin binding pro-
teins, enforcing the integrin-cytoskeleton connection. As
it turns out for integrin-linked kinase (ILK), such adapter
function might be even more important in vivo than the
kinase function demonstrated in vitro.
The integrin αVβ6 is expressed principally on epithelial
cells [8] where it has been shown to be a receptor for RGD
and non-RGD sites in ligands [9]. It is demonstrated that
the mature form of TGFβ1 binds to and activates of αVβ6
integrin [10]. Among others, binding of mature TGFβ1 to
αVβ6 integrin resulted in an enhanced immobilization and
phosphorylation of proteins, which are associated with
focal adhesions [10,11]. Surprisingly, stimulation with
mature TGFβ1 leads to upregulation of c-Jun in TGFβ1 sen-
sitive cells [10]. We therefore sought to determine if
mature TGFβ1 activates c-Jun via MEKK1/p38 and if this
activation may influence cytoskeletal reorganization.
Here, we show that binding of mature TGFβ1 recruits the
mitogen-activated protein kinase kinase kinase 1
(MEKK1), a mediator of c-Jun activation, and the extracel-
lular signaling-regulated kinase-1 (Erk1) to focal adhe-
sions. In addition, the p21-activated kinase 1 (PAK1) is
associated with focal adhesions and differentially phos-
phorylated upon stimulation with mature TGFβ1. We con-
clude that TGFβ1 activates c-Jun via the MEKK1/p38 MAP
kinase pathway and influences cytoskeletal organization.
These finding may provide a link between TGFβ1 and met-
astatic behavior of cancers.
Crosstalk between integrins and growth factor receptors
are an important signaling mechanism to provide specifi-
city during normal development and pathological proc-
esses in vascular biology. Evidence from several model
systems demonstrates the physiological importance of the
coordination of signals from growth factors and the extra-Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/33
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cellular matrix to support cell proliferation, migration,
and invasion in vivo [12–14]. Several examples of
crosstalk between these two important classes of receptors
indicate that integrin ligation is required for growth fac-
tor-induced biological processes [15]. Furthermore,
integrins can directly associate with growth factor recep-
tors, thereby regulating the capacity of integrin/growth
factor receptor complexes to propagate downstream sign-
aling [10,11,16].
We have demonstrated that mature TGFβ1  colocalizes
with αVβ6 integrin in Panc-1 cells [10]. To further support
our initial findings, we assayed for colocalization between
TGFβ1,  αVβ6  integrin and the F-actin filaments of the
cytoskeleton in SW48, DLD1, HeLa cells as well as kerati-
nocytes. Cells were stimulated with 10 nM of mature
TGFβ1. After preparation of the cytoskeletal fraction by
Triton-X100 extraction [10,17,18], slides were stained
using Alexa Fluor 680 goat anti-mouse IgG (Molecular
Probes, Eugene, OR) for Actin, Alexa Fluor 488 donkey
anti-rabbit IgG (Molecular Probes) for αVβ6 integrin, and
Alexa Fluor 350 donkey anti-rabbit IgG (Molecular
Probes) for TGFβ1 labeling [10]. As shown in Figure 1, in
TGFβ1,  αVβ6 integrin and the F-Actin filaments of the
cytoskeleton colocalize after stimulation with mature
TGFβ1 in all cell lines used. These results further support
Colocalization of TGFβ1, αVβ6 integrin and the cytoskeleton Figure 1
Colocalization of TGFβ1, αVβ6 integrin and the cytoskeleton. 10,000 cells(SW48, DLD1, HeLa, keratinocytes) were 
cultured on glass coverslips in DMEM supplemented with 17% of heat inactivated fetal bovine serum and stimulated with 10 nM 
of mature TGFβ1 (from R&D Systems) for ten minutes. After preparation of the cytoskeletal fraction by Triton-X100 extrac-
tion [10], slides were stained using Alexa Fluor 680 goat anti-mouse IgG (Molecular Probes, Eugene, OR) for actin (sc-8432, 
Santa Cruz), Alexa Fluor 488 donkey anti-rabbit IgG (Molecular Probes) for αVβ6 integrin (sc-6617 and sc-6632), and Alexa 
Fluor 350 donkey anti-rabbit IgG (Molecular Probes) for TGFβ1 (sc-146) labeling and viewed using a Zeiss LSM-510 confocal 
microscope [10]. Magnification 1000 ×.
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our initial findings that mature TGFβ1 is a ligand for αVβ6
integrin.
Adhesion to the extracellular matrix is an important proc-
ess that controls cell shape change, migration, prolifera-
tion, survival, and differentiation. Upon adhesion,
integrins and a selective group of cytoskeletal and signal-
ing proteins are recruited to cell matrix contact sites where
they link the actin cytoskeleton to the ECM and mediate
signal transduction between the intracellular and extracel-
lular compartments [18].
We demonstrated that mature TGFβ1 induces an enhanced
immobilization and phosphorylation of proteins, which
are associated with focal adhesions, in TGFβ1 sensitive
cells [10]. In order to provide further evidence for the spe-
cificity of this interaction, we preincubated cells with anti-
bodies against αVβ8, αVβ6, αVβ5, αVβ3, and αVβ1 integrins
prior to stimulation with mature TGFβ1. Consistent with
our initial report, preincubation with αVβ6  antibodies
abolished the TGFβ1-induced tyrosine phosphorylation of
proteins, which are associated with focal adhesions (Fig-
ure 2). In sum, we could confirm our initial findings that
mature TGFβ1 is a ligand for αVβ6 integrin and that this
association results in immobilization and tyrosine phos-
phorylation of proteins, which are associated with focal
adhesions, in TGFβ1 sensitive cells.
Paxillin is a multi-domain protein that localizes in cul-
tured cells primarily to sites of cell adhesion to the
Phosphorylation and immobilization of proteins associated with focal adhesions Figure 2
Phosphorylation and immobilization of proteins associated with focal adhesions. Cytoskeletally anchored αVβ6 was 
immunoprecipitated after TGFβ1 stimulation (10 nM for 10 minutes) followed by Western analysis with antibodies against tyro-
sine-phosphorylated proteins or αV integrin. In part the cells were preincubated with αV- and β8-, β6-, β5-, β3-, and β1-antibod-
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extracellular matrix (ECM) called focal adhesions [6].
Focal adhesion proteins including paxillin also serve as a
point of convergence for signals resulting from stimula-
tion of various classes of growth factor receptors [19,20].
It binds to many proteins that are involved in effecting
changes in the organization of the actin cytoskeleton,
which are necessary for cell motility events associated
with embryonic development, wound repair and tumor
metastasis. These range from structural proteins such as
vinculin and actopaxin, that bind actin directly to regula-
tors of actin cytoskeletal dynamics, such as the ARF GAP,
PKL, the exchange factor PIX and the p21-activated kinase,
PAK. These proteins serve as modulators/effectors of the
ARF and RHO GTPase families [6,7]. In our assays, Paxil-
lin was found to be phosphorylated at Y118 after stimula-
tion and associated with focal adhesions after stimulation
of BxPC-3 cells with mature TGFβ1 (Figure 3). This phos-
phorylation was dependent on an intact cytoskeleton as
well as free intracellular calcium (Figure 3).
Both paxillin and focal adhesion kinase (FAK) undergo
phosphorylation during integrin-mediated cell adhesion
and during stimulation by a variety of mitogens and
growth factors [6,7]. There is growing evidence that
integrins function as mechanotransducers and that the
regulation of cellular responses to mechanical stimuli is
coordinated by the complex of cytoskeletal proteins that
associate with the cytoplasmic domains of integrin
molecules [17]. In cultured cells, FAK and paxillin
undergo tyrosine phosphorylation in response to periods
Paxillin and c-Jun are associated with focal adhesions Figure 3
Paxillin and c-Jun are associated with focal adhesions. BxPC-3 cells were stimulated with 10 nM of mature TGFβ1 for 
ten minutes followed by preparation of the Triton-X100 nonsoluble fraction and precipitation with αVβ6 integrin antibodies. 
The precipitate was then re-precipitated with anti-FAK antibodies (sc-1688) and analyzed with antibodies against p-PaxillinY118 
(2541, Cell Signaling) and p-c-JunS63 (9621, Cell Signaling). In part, the cells were preincubated with a TGFβ-RII antibody (Santa 
Cruz), BAPTA-AM and Cytochalasin D, respectively [10].
12 3 4
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of repetitive mechanical strain [17,18]. In a number of
cultured cell types, including endothelial cells and airway
smooth muscle cells, cyclic mechanical strain has been
shown to induce the alignment of actin filaments along
the axis perpendicular to the force vector [17,18]. Paxillin
and FAK were identified as integration points in signaling
proximal to integrins and growth-factor receptors. We
speculate that the conversion of growth-factor and adhe-
sion signaling occurs on the actin filaments. The cytoplas-
mic domains of integrins and receptors for growth factors
and cytokines are closely associated with the ends of the
cytoskeleton; reorganization of microfilaments may influ-
ence the environment of these integrins and receptors,
thereby facilitating the triggering of a signaling pathway.
The mechanisms are obscure.
Activation of paxillin/FAK by integrins and growth factors
is important for efficient signal propagation by pathways
including paxillin that lead to the regulation growth and
differentiation. A similar role for FAK was described in the
control of growth factor- and integrin-mediated cell
migration in fibroblasts [21]. This suggests that paxillin/
FAK have a general role in linking integrins/growth-factor
receptors with the regulation of cytoskeletal changes that
controls various biological processes in different cells.
Paxillin and FAK have been proposed to play an integral
role in these strain-induced morphological changes.
Reorganization of the cytoarchitecture regulates signaling
pathways including the mobilization of intracellular cal-
cium, activation of tyrosine kinases, Ras, extracellular sig-
MEKK1 is associated with focal adhesions Figure 4
MEKK1 is associated with focal adhesions. BxPC-3 cells were stimulated with 10 nM of mature TGFβ1 for ten minutes 
followed by preparation of the Triton-X100 nonsoluble fraction and precipitation with αVβ6 integrin antibodies. The precipitate 
was then re-precipitated with anti-FAK antibodies (sc-1688) and analyzed with a MEKK1 antibody (sc-448). In part, the cells 
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nal-regulated kinase (ERK), and c-Jun NH2-terminal
kinase (JNK). Consistent with the activation of signaling
pathways, specific transcription factors are activated by
cytoskeletal restructuring [10,11,17]. We stimulated
BxPC-3 cells with 10 nM of mature TGFβ1, prepared the
Triton-X100 nonsuluble fraction, precipitated with αVβ6
integrin antibodies followed by re-precipitation with FAK
antibodies. Our assays revealed that MEKK1 and c-Jun are
phosphorylated and associated with focal adhesions after
stimulation of BxPC-3 cells with mature TGFβ1 (Figures 3
and 4). Our findings are in part supported by Verrecchia
et al showing that TGFβ induces c-Jun and JunB [22]. In
addition, our finding that MEKK1 associates with focal
adhesions finds support in the report from Cuevas et al
[23]. Cuevas et al show evidence that MEKK1 colocalizes
with focal adhesions in adhering MEKK1-/- fibroblasts
reconstituted with EGFP-MEKK1 [23]. However, this is
the first report that c-Jun is associated with the cytoskele-
ton, whilst phosphorylated.
MEKK1 is absolutely required for cellular responses,
which alter the integrity of the microtubule cytoskeleton
and cell shape; MEKK1 is the MAPK kinase kinase regulat-
ing the JNK pathway [24,25]. The significance for a
cytoskeletal immobilization of c-Jun is not known. We
also detected Erk1 associated with focal adhesions in
BxPC-3 cells, stimulated with 10 nM of mature TGFβ1
(Figure 5). Most strikingly, we observed two bands for the
phosphorylated form of Erk1. These bands are not visible
after incubation with phosphatases (data not shown).
Erk1 is associated with focal adhesions Figure 5
Erk1 is associated with focal adhesions. BxPC-3 cells were stimulated with 10 nM of mature TGFβ1 for ten minutes fol-
lowed by preparation of the Triton-X100 nonsoluble fraction and precipitation with αVβ6 integrin antibodies. The precipitate 
was then re-precipitated with anti-FAK antibodies (sc-1688) and analyzed with an Erk1 antibody (sc-93). In part, the cells were 
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The mitogen-activated protein kinase, referred to as MAP
kinase or extracellular signal-regulated kinase (ERK), is a
serine/threonine protein kinase whose activity is rapidly
stimulated by a number of external stimuli through mech-
anisms mediated by tyrosine kinase-encoded receptors,
non-receptor type tyrosine kinases, and G protein-cou-
pled receptors. MAP kinase is activated by phosphoryla-
tion on its threonine and tyrosine residues, a process,
which is carried out by a dual-specificity protein kinase,
MAP kinase kinase. MAP kinases have been shown to
phosphorylate and thereby activate many well studied
regulatory proteins located in diverse cellular compart-
ments, including nuclear transcriptional factors [26]. A
function of MAP kinases may therefore be to provide a
link between transmembrane signaling and the nucleus.
There is much evidence that MAP kinases may be involved
in cell growth and differentiation by phosphorylating and
thereby activating nuclear transcriptional factors [27].
Meanwhile, there are many compelling examples of gene
expression induced by adhesive interactions with ECM
[28–30]. Thus, MAP kinase may play a pivotal role in
adhesion-dependent gene activation through the integrin-
mediated signaling pathways. The fact that MAP kinase is
activated by both, growth factor- and integrin-mediated
signals, suggests that these two signaling pathways
converge at this or upstream points. However, resolving
the nature and degree of interactions between integrin-
and growth factor-mediated signaling pathways, and their
relative contributions, must await more complete defini-
Pak1 is associated with focal adhesions Figure 6
Pak1 is associated with focal adhesions. BxPC-3 cells were stimulated with 10 nM of mature TGFβ1 for ten minutes fol-
lowed by preparation of the Triton-X100 nonsoluble fraction and precipitation with αVβ6 integrin antibodies. The precipitate 
was then reprecipitated with anti-FAK antibodies (sc-1688), followed by re-precipitation with anti-phosphoS (ab9334, Abcam), 
anti-phosphoThr (ab2286), and analyzed with a Pak1 antibody (71-9300, Zymed). In part, the cells were preincubated with 50 
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tion and understanding of integrin-mediated growth-fac-
tor-induced signal transduction pathways.
Hyperactive Erk may phosphorylate Tau in an abnormal
fashion. Tau hyperphosphorylation by abnormaly active
Erk is demonstrated in neuroblastoma cells, suggesting
that abnormak Erk activity function as apoptosis inducing
kinase [31]. Additional factors may compensate this
effect, leading to resistance to apoptosis, multidrug resist-
ance, or metastatic behavior of cancers [32,33]. Support
for this speculation comes from another report showing
that the family of p21 activated kinases (PAK) is involved
in actin cytoskeleton organization [34,35].
The p21-activated kinases (PAKs) are serine/threonine
protein kinases that bind to and, in some cases, are
stimulated by activated forms of the small GTPases,
Cdc42 and Rac [36]. The PAK family of kinases has been
implicated in control of actin filaments and in cell motil-
ity. Targets for PAK are likely to be involved in migration,
including myosin light chain kinase (MLCK) and LIM
kinase. MLCK phosphorylates MLC, and this phosphor-
ylation has been shown to be important in regulating
actin cytoskeletal dynamics. In addition, PAK phosphor-
ylates and activates LIMK, which in turn phosphorylates
and inhibits the actin severing protein cofilin, thus pro-
moting filament assembly. The PAK interacting guanine
nucleotide exchange factor PIX, the ARF GTPase activating
protein PKL, and the adaptor protein Nck, are also medi-
ators of Rho GTPase signaling; they form a complex with
PAK to regulate the actin cytoskeleton and stimulate focal
complex formation through paxillin interactions. G pro-
tein coupled receptor kinase interacting protein (GIT1)
links PAK to FAK and results in focal contact turnover,
while another protein, p95 APP 1, of the GIT family, has
been implicated in membrane recycling during locomo-
tion, suggesting a role of GIT family members in cell
motility [37]. Thus, PAK plays an important role in Rac-
driven cell motility through several different signaling
cascades.
The Erk-MAP kinase, including PAK, PI3K, and MEKK1,
have been linked to motility [38]. Rac can regulate several
different pathways through different effectors. Rac acti-
vates PI3K and AKT independent of JNK, and activates the
MEKK-JNK cascade independent of PAK. In addition to
the Rac-MEKK-JNK and the ERK cascades, PI3K-AKT has
also been shown to promote cell migration.
We found that Pak1 is associated with focal adhesions
upon stimulation of BxPC-3 cells with 10 nM of mature
TGFβ1  (Figure 6). The Src family kinase inhibitor 4-
amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo- [3,4-d]-
pyrimidine (PP2) significantly reduced the phosphoryla-
tion level of Pak1 compared with the MEK1 inhibitor
PD98059. The effect of the MEK1 inhibitor on the Pak1
phosphorylation is striking because Pak1 is considered
upstream of MEK1/Erk [39]. It is possible that other sign-
aling molecules mediate a crosstalk between the two path-
ways. Notably, the src-inhibitor PP2 partially reduced the
Pak1 phosphorylation level. Blocking of Pak activity is
considered a so called "signal therapy for Ras-induced
cancers" [40,41].
As is clear from this study, there is a lot that remains to be
understood about the integrin-mediated signal
transduction elicited by mature TGFβ1 [42,43]. Further
studies will provide us with answers in the near future that
will shed light on many of the remaining mysteries of the
TGFβ puzzle.
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